Final-Program-ATS-2023-AP.vp

316

WEDNESDAY • MAY 24

709 Immune Response to COVID-19 Vaccine in Patients on Asthma Biologics/ S. Khurana, Rochester, NY 710 Risk Factors for Symptomatic SARS-CoV2 Infection, Severe COVID-19, and Vaccination Response in the Severe Asthma Research Program/ A.M. Rusk, Phoenix, AZ 711 Autoantibodies Are Prevalent in Hospitalized COVID-19 Patients, But Are Not Associated With Short-term Outcomes/ A. Pacheco-Navarro, Stanford, CA 712 Proteomic Analysis of Serum From IVIG-treated COVID-19 Patients Uncovered Suppression of Neutrophil-related Pathways/ J.A. Masso Silva, La Jolla, CA 713 Effects of Primary Immunodeficiency on COVID Admission Outcomes in the United States: Nationwide Analysis/ R. Dalbah, Johnson City, TN 714 Differences in Sterol Metabolites in Survivors of COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)/ L. Leuenberger, Columbus, OH 715 Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical and Biologic Effects of Anti-CD14 Treatment in Hospitalized Patients With COVID-19/ L. Mabrey, Seattle, WA 716 The Therapeutic Path in the Post-COVID Thicket - Renaissance of Azithromycin/ D. Gagiannis, Ulm, Germany 717 Safety and Tolerability of LYT-100 (Deupirfenidone) in Post-Acute Sequelae of SARS-CoV-2 (PASC) “Long COVID” Patients Presenting With Respiratory Complications/ T. Kulkarni, Birmingham, AL 718 Pulmonary Function and Radiological Follow-up in Patients With CT Abnormalities After Virological Recovery From COVID-19/ A. Jain, Valhalla, NY 719 Pathogenesis of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Accessory Protein Open Reading Frame 7b (Orf7b) in Thymus-cell (T-cell) Lymphopenia/ R. Deshpande, Pittsburgh, PA 720 Pulmonary Function Testing in Recovered COVID-19 Omicron Variant Outpatients/ S. Copen, Los Angeles, CA 721 Mortality Differences Among Patients With Airway Disease Hospitalized With COVID-19/ Y. Liu, New Haven, CT 722 Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study/ F. Schleich, Liège, Belgium 723 The Impact of Asthma and Metabolic Syndrome in COVID-19: An Analysis of the Virus COVID-19 Registry/ J.L. Denson, New Orleans, LA 724 Impact of the COVID-19 Pandemic on Clinic Visit Behavior Among Adult Patients With Asthma/ T. Tajiri, Nagoya, Japan

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

D22

HOT TOPICS IN BEHAVIORAL SCIENCES AND HEALTH SERVICES RESEARCH

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 151 A (Street Level)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

Chairing: C.H. Weiss, MD, Evanston, IL

A. Norweg, PhD, BS, MS, New York, NY R. Kohn, MD, MSCE, Philadelphia, PA 401 A Telehealth Approach to Addressing ICU Healthcare Worker Mental Health Distress: Initial Data and Uptake of Resiliency Services/ N. Shah, Charleston, SC 402 Do Prognostic Scores Perform Differently in Surge-strained Hospitals? Impact of Surge Index on COVID-19 Mortality Prediction by the Modified 4C Score at 224 U.S. Hospitals, March-May 2020/ C. Yek, Bethesda, MD 403 Association of Hospital Mortality With Initiation of Mechanical Ventilation on a Weekend: A Retrospective Cohort Study/ K. Rai, Aurora, CO 404 Variation in Receipt of Imaging Among Patients Presenting With Dyspnea in Emergency and Ambulatory Settings/ S. Cabral, Boston, MA 405 Endobronchial Ultrasound Transbronchial Needle Aspiration With Vs Without Rapid On-site Evaluation in Diagnosing Mediastinal and Pulmonary Lesions: A Systematic Review and Metanalysis/ A. Elkhapery, Rochester, NY 406 Assessing the Robustness of a Machine Learning Model for Predicting Asthma Hospital Encounters During the COVID-19 Pandemic/ X. Zhang, Seattle, WA 407 Assessing the Impact of AI Based Prioritization and Triage of Positive Non-CTPAs on Wait Time in the Outpatient Setting/ D.A. Klein, Summit, NJ 408 Examining Changes in Antibiotic Usage Among Inpatients With Asthma Between 2010-2018/ S. Chokkara, Chicago, IL 409 Exploring Provider Conceptualization of Limited Life Expectancy in the Context of Lung Cancer Screening: A Qualitative Study/ L. Kearney, Boston, MA 410 Veteran Perceptions of Lung Cancer Risk and Implications for Lung Cancer Screening Programs/ J. Boudreau, Bedford, MA

ATS 2023 • Washington, DC